scholarly article | Q13442814 |
P356 | DOI | 10.1080/10428190802272684 |
P698 | PubMed publication ID | 18661393 |
P50 | author | Jonathan S. Serody | Q38327188 |
Timothy P Moran | Q57011491 | ||
James M Coghill | Q63136136 | ||
P2093 | author name string | Michael J Carlson | |
P2860 | cites work | Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse | Q24290693 |
JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome | Q24626901 | ||
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3 | Q24672849 | ||
Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome | Q24679039 | ||
Control of regulatory T cell development by the transcription factor Foxp3 | Q27860489 | ||
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 | ||
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission | Q28290182 | ||
Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25- T cells through Foxp3 induction and down-regulation of Smad7 | Q28591451 | ||
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival | Q29547865 | ||
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells | Q29618394 | ||
An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 | ||
The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 | Q29619324 | ||
CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production | Q29619536 | ||
Leukocyte migration and graft-versus-host disease | Q30479618 | ||
Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia | Q33629928 | ||
An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation | Q33876035 | ||
Acute graft-vs-host disease: pathobiology and management | Q33940061 | ||
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance | Q34111451 | ||
CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor | Q34116317 | ||
Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. | Q34509694 | ||
Human T regulatory cells can use the perforin pathway to cause autologous target cell death | Q34551876 | ||
Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells | Q34600272 | ||
Thymus and Reproduction: Sex-Linked Dysgenesia of the Gonad after Neonatal Thymectomy in Mice | Q34705919 | ||
Chronic graft versus host disease | Q35772587 | ||
Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease | Q35848361 | ||
Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease | Q35848458 | ||
Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. | Q35989486 | ||
Regulatory functions of CD8+CD28– T cells in an autoimmune disease model | Q36001202 | ||
Acute graft versus host disease | Q36059671 | ||
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells | Q36228688 | ||
Myeloid suppressor cells in cancer: recruitment, phenotype, properties, and mechanisms of immune suppression | Q36259867 | ||
Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 | ||
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes | Q36399048 | ||
CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner | Q36403637 | ||
Graft-versus-host disease | Q36793622 | ||
Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. | Q40565739 | ||
Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response | Q40651436 | ||
CCR6 regulates the function of alloreactive and regulatory CD4+ T cells during acute graft-versus-host disease | Q43449016 | ||
CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 | ||
Association of Foxp3 regulatory gene expression with graft-versus-host disease | Q44917891 | ||
Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells | Q46025217 | ||
A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma | Q47614903 | ||
L-Selectin(hi) but not the L-selectin(lo) CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection | Q50796687 | ||
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma | Q51985543 | ||
Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation | Q53557826 | ||
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation | Q53589050 | ||
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. | Q53646174 | ||
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma | Q56903494 | ||
P433 | issue | 10 | |
P921 | main subject | bone marrow | Q546523 |
P304 | page(s) | 1860-1869 | |
P577 | publication date | 2008-10-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Leukemia & Lymphoma | Q6534493 |
P1476 | title | The biology and therapeutic potential of natural regulatory T-cells in the bone marrow transplant setting | |
P478 | volume | 49 |